{"product_id":"eloralintide-10mg","title":"Eloralintide 10mg","description":"\n\u003cdiv class=\"riptidez-product\"\u003e\n\n  \u003ch2\u003eEloralintide 10 mg | Research Peptide\u003c\/h2\u003e\n\n  \u003cp\u003e\u003cstrong\u003eExploring a Different Pathway in Metabolic Research.\u003c\/strong\u003e\u003c\/p\u003e\n\n  \u003cp\u003e\n    Eloralintide (LY3841136) is an investigational selective\n    amylin receptor agonist attracting scientific interest\n    for its role in appetite signaling, satiety, and\n    metabolic regulation.\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    While GLP-1 research has received significant attention,\n    eloralintide represents a different approach by\n    targeting the amylin signaling pathway.\n  \u003c\/p\u003e\n\n  \u003chr\u003e\n\n  \u003ch3\u003eWhat Is Eloralintide?\u003c\/h3\u003e\n\n  \u003cp\u003e\n    Eloralintide is an investigational peptide designed\n    to preferentially activate the amylin-1 receptor\n    (AMY1R).\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    Amylin is a naturally occurring hormone released\n    alongside insulin after eating. It helps communicate\n    signals related to fullness and food intake.\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    By studying this pathway, researchers are gaining\n    a better understanding of the complex signals\n    involved in metabolic regulation.\n  \u003c\/p\u003e\n\n  \u003ch3\u003eAreas of Scientific Interest\u003c\/h3\u003e\n\n  \u003cul\u003e\n    \u003cli\u003eAmylin receptor activity and signaling\u003c\/li\u003e\n    \u003cli\u003eAppetite and satiety pathways\u003c\/li\u003e\n    \u003cli\u003eMetabolic regulation\u003c\/li\u003e\n    \u003cli\u003eBody-weight regulation in clinical research\u003c\/li\u003e\n    \u003cli\u003eInteractions with incretin signaling pathways\u003c\/li\u003e\n  \u003c\/ul\u003e\n\n  \u003ch3\u003eHow Is Eloralintide Different from GLP-1?\u003c\/h3\u003e\n\n  \u003cp\u003e\n    Both GLP-1 and amylin pathways are involved in\n    metabolic signaling, but they operate through\n    different receptors.\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    GLP-1 receptor agonists target the GLP-1 receptor,\n    while eloralintide preferentially targets AMY1R.\n    Researchers are investigating these pathways\n    individually and in combination to better\n    understand their biological effects.\n  \u003c\/p\u003e\n\n  \u003ch3\u003eCurrent Research\u003c\/h3\u003e\n\n  \u003cp\u003e\n    Published Phase 2 clinical research has investigated\n    eloralintide in adults with obesity or overweight.\n    Research has examined body-weight outcomes,\n    tolerability, and metabolic measures.\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    Eloralintide has advanced into Phase 3 clinical\n    investigation and remains an investigational\n    compound without FDA approval.\n  \u003c\/p\u003e\n\n  \u003chr\u003e\n\n  \u003ch3\u003eProduct Specifications\u003c\/h3\u003e\n\n  \u003cul\u003e\n    \u003cli\u003e\n\u003cstrong\u003eCompound:\u003c\/strong\u003e Eloralintide\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eResearch Identifier:\u003c\/strong\u003e LY3841136\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eNominal Amount:\u003c\/strong\u003e 10 mg per vial\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eClassification:\u003c\/strong\u003e Selective Amylin Receptor Agonist\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eResearch Area:\u003c\/strong\u003e Metabolic Signaling\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eIntended Application:\u003c\/strong\u003e Laboratory Research Only\u003c\/li\u003e\n\n  \u003chr\u003e\n\n  \u003ch3\u003eResearch Use Only\u003c\/h3\u003e\n\n  \u003cp\u003e\n    \u003cstrong\u003e\n      FOR RESEARCH USE ONLY — NOT FOR HUMAN OR\n      VETERINARY USE.\n    \u003c\/strong\u003e\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    Eloralintide is an investigational compound.\n    It is not FDA-approved. This product is not\n    intended for human consumption, clinical use,\n    self-administration, or veterinary applications.\n    It is not intended to diagnose, treat, cure,\n    or prevent any disease.\n  \u003c\/p\u003e\n\n  \u003ch3\u003eExplore More Research\u003c\/h3\u003e\n\n  \u003cp\u003e\n    Interested in learning more about metabolic\n    signaling and peptide research?\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    \u003ca href=\"\/pages\/research-library\"\u003e\n      Explore the Riptidez Research Library\n    \u003c\/a\u003e\n  \u003c\/p\u003e\n\n  \u003cp\u003e\n    \u003ca href=\"\/pages\/peptides-studied-for-metabolic-research\"\u003e\n      Explore Metabolic Research Peptides\n    \u003c\/a\u003e\n  \u003c\/p\u003e\n\n\u003c\/ul\u003e\n\u003c\/div\u003e\n","brand":"Riptidez LLC","offers":[{"title":"Default Title","offer_id":68099162701867,"sku":null,"price":75.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/6603\/8315\/files\/eloralintide10mg.png?v=1793565603","url":"https:\/\/riptidez.net\/products\/eloralintide-10mg","provider":"Riptidez LLC","version":"1.0","type":"link"}